Detalles de la búsqueda
1.
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluation.
BMC Infect Dis
; 24(1): 233, 2024 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38383310
2.
Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.
BMC Genomics
; 23(1): 561, 2022 Aug 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35931954
3.
Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).
BMC Pulm Med
; 19(1): 124, 2019 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31291943
4.
Mycobacterium tuberculosis Uganda II is more susceptible to rifampicin and isoniazid compared to Beijing and Delhi/CAS families.
BMC Infect Dis
; 16: 173, 2016 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27097724
5.
Variation and risk factors of drug resistant tuberculosis in sub-Saharan Africa: a systematic review and meta-analysis.
BMC Public Health
; 15: 291, 2015 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25880829
6.
The Mycobacterium tuberculosis Uganda II family and resistance to first-line anti-tuberculosis drugs in Uganda.
BMC Infect Dis
; 14: 703, 2014 Dec 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25523472
7.
Evaluation of Xpert MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
PLoS One
; 18(8): e0284545, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37590288
8.
Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda.
PLoS One
; 18(3): e0282650, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36897841
9.
Evaluation of Xpert ® MTB/XDR test for susceptibility testing of Mycobacterium tuberculosis to first and second-line drugs in Uganda.
medRxiv
; 2023 Apr 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37066316
10.
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Antimicrob Resist Infect Control
; 11(1): 68, 2022 05 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35550202
11.
Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory.
PLoS One
; 16(5): e0251691, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33989348
12.
Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.
PLoS One
; 13(5): e0198091, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29847567
13.
Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
Infect Genet Evol
; 40: 8-16, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26917365
14.
Anti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national survey.
PLoS One
; 8(8): e70763, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23936467
Resultados
1 -
14
de 14
1
Próxima >
>>